Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M705653200 on January 2, 2008

J. Biol. Chem., Vol. 283, Issue 9, 5542-5553, February 29, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/9/5542    most recent
M705653200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, S.
Right arrow Articles by Xiao, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, S.
Right arrow Articles by Xiao, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

General Transcription Factor IIA-{gamma} Increases Osteoblast-specific Osteocalcin Gene Expression via Activating Transcription Factor 4 and Runt-related Transcription Factor 2*Formula

Shibing Yu{ddagger}, Yu Jiang§, Deborah L. Galson{ddagger}, Min Luo{ddagger}, Yumei Lai{ddagger}, Yi Lu{ddagger}, Hong-Jiao Ouyang{ddagger}, Jian Zhang{ddagger}, and Guozhi Xiao{ddagger}1

From the Departments of {ddagger}Medicine and §Pharmacology, University of Pittsburgh, Pittsburgh, Pennsylvania 15240

ATF4 (activating transcription factor 4) is an osteoblast-enriched transcription factor that regulates terminal osteoblast differentiation and bone formation. ATF4 knock-out mice have reduced bone mass (severe osteoporosis) throughout life. Runx2 (runt-related transcription factor 2) is a runt domain-containing transcription factor that is essential for bone formation during embryogenesis and postnatal life. In this study, we identified general transcription factor IIA{gamma} (TFIIA{gamma}) as a Runx2-interacting factor in a yeast two-hybrid screen. Immunoprecipitation assays confirmed that TFIIA{gamma} interacts with Runx2 in osteoblasts and when coexpressed in COS-7 cells or using purified glutathione S-transferase fusion proteins. Chromatin immunoprecipitation assay of MC3T3-E1 (clone MC-4) preosteoblast cells showed that in intact cells TFIIA{gamma} is recruited to the region of the osteocalcin promoter previously shown to bind Runx2 and ATF4. A small region of Runx2 (amino acids 258–286) was found to be required for TFIIA{gamma} binding. Although TFIIA{gamma} interacts with Runx2, it does not activate Runx2. Instead, TFIIA{gamma} binds to and activates ATF4. Furthermore, TFIIA{gamma} together with ATF4 and Runx2 stimulates osteocalcin promoter activity and endogenous mRNA expression. Small interfering RNA silencing of TFIIA{gamma} markedly reduces levels of endogenous ATF4 protein and Ocn mRNA in osteoblastic cells. Overexpression of TFIIA{gamma} increases levels of ATF4 protein. Finally, TFIIA{gamma} significantly prevents ATF4 degradation. This study shows that a general transcription factor, TFIIA{gamma}, facilitates osteoblast-specific gene expression through interactions with two important bone transcription factors ATF4 and Runx2.


Received for publication, July 10, 2007 , and in revised form, December 31, 2007.

* This work was supported by National Institutes of Health Grant DK072230 and Department of Defense Grant W81XWH-07-1-0160 (to G. X.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1 and S2.

1 To whom correspondence should be addressed: Division of Hematology/Oncology, Dept of Medicine, University of Pittsburgh, Veterans Affairs Pittsburgh Healthcare System, Research and Development, 151-U, Rm. 2W-111, University Dr. C, Pittsburgh, PA 15240. Tel.: 412-688-6000 (Ext. 814459); Fax: 412-688-6960; E-mail: xiaog{at}upmc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
H. Tominaga, S. Maeda, M. Hayashi, S. Takeda, S. Akira, S. Komiya, T. Nakamura, H. Akiyama, and T. Imamura
CCAAT/Enhancer-binding Protein {beta} Promotes Osteoblast Differentiation by Enhancing Runx2 Activity with ATF4
Mol. Biol. Cell, December 1, 2008; 19(12): 5373 - 5386.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. M. Thiaville, E. E. Dudenhausen, K. S. Awad, A. Gjymishka, C. Zhong, and M. S. Kilberg
Activated transcription via mammalian amino acid response elements does not require enhanced recruitment of the Mediator complex
Nucleic Acids Res., October 1, 2008; 36(17): 5571 - 5580.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement